Physician profile
Amanda Graff
NPI 1265165948
$2,219.69
in general payments reported to CMS, 2019-2025
20 companies · $1,378 in 2025
The $1,378 reported for 2025 was more than what 88% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $107 · 2024: $735 · 2025: $1,378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,220.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,219.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $438.99 | 2024-2025 | Gemtesa, Orgovyx |
| Antares Pharma, INC. | $385.78 | 2024-2025 | Xyosted |
| Merck Sharp & Dohme LLC | $337.49 | 2023-2025 | Keytruda, Lynparza |
| Janssen Biotech, INC. | $150.11 | 2024-2025 | Erleada, Akeega, Balversa |
| Boston Scientific Corporation | $147.35 | 2025 | Ams 700 |
| Endo USA, INC. | $89.21 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $87.12 | 2025 | Adstiladrin |
| Vertex Pharmaceuticals Incorporated | $82.72 | 2025 | |
| Astellas Pharma US INC | $71.73 | 2024-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $71.40 | 2023-2024 | Aveed, Xiaflex |
| Dendreon Pharmaceuticals LLC | $63.00 | 2025 | Provenge |
| Organogenesis INC. | $62.13 | 2024-2025 | Apligraf |
| Smith+Nephew, INC. | $54.60 | 2024-2025 | Collagenase Santyl, Grafix Pl |
| Solventum Corporation | $43.82 | 2024 | Activ.A.C., Prevena, V.A.C. Veraflo |
| Integra Lifesciences Corporation | $36.94 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $23.50 | 2023 | Octagam Immune Globulin (Human) |
| Abc Home Medical Supply, INC. | $22.03 | 2024 | |
| Pfizer INC. | $19.65 | 2025 | |
| Abbvie INC. | $18.67 | 2024 | |
| Coloplast Corp | $13.45 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Graff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.